Lung cancer patients who received IV immunotherapy doses earlier in the day tended to live longer, researchers reported in a ...

Medicaid expansion is associated with lower 2- and 4-year mortality among patients with resectable non-small cell lung cancer ...

Both immunotherapy drugs work by blocking cancer cells’ ability to evade detection by the immune system, according to ...

Patients with extensive-stage SCLC who received immunochemotherapy before 15:00 hrs exhibited significantly longer PFS, overall survival.

Receiving anticancer immunotherapy earlier in the day may help individuals with cancer live longer. That's according to a ...

Researchers conduct a retrospective analysis of patients with SCLC who receive immunochemotherapy at different times of day.

Lung cancer stands as a formidable health challenge, claiming more lives globally than any other type of cancer. This sobering reality is largely attributed to the unfortunate truth that the disease ...

Squamous cell carcinoma treatment varies by stage, involving surgery, radiation, and systemic therapies based on cancer ...

Thanks to recent therapy advances, the lung cancer mortality rate has declined and survival rates have improved. Many factors influence the likelihood of a lung cancer cure or long-term survival, ...

Pneumonia and lung cancer present similar symptoms like cough and chest pain. Pneumonia is a rapid infection, while lung ...

A cough that lingers for weeks is never normal. Oncologist Dr Manish Sahni explains the early signs of lung cancer and why ...